期刊文献+

乳腺癌转移抑制基因1通过金属蛋白酶组织抑制因子-2/基质金属蛋白酶-2途径抑制胶质瘤细胞侵袭 被引量:7

Breast cancer metastasis suppressor-1 inhibits human glioma cells invasion by tissue inhibitor of metalloproteinase-2/matrix metalloproteinase-2 pathway
原文传递
导出
摘要 目的 探讨抑癌基因乳腺癌转移抑制基因1(BRMS1)影响胶质瘤细胞侵袭的机制.方法 将真核表达质粒pEGFP-BRMS1和对照质粒pEGFP-N2分别转入人胶质瘤U251和U87细胞中,Western blot技术检测BRMS1蛋白表达,人工基底膜侵袭实验检测细胞侵袭能力,明胶酶谱实验检测胶质瘤细胞分泌基质金属蛋白酶-2(MMP-2)的活性,Western blot检测金属蛋白酶组织抑制因子-2(TIMP-2)及MMP-2蛋白表达.结果 与对照组比较,转染pEGFP-BRMS1质粒24 h后U251和U87细胞侵袭力分别下降了43%和52%,差异均有统计学意义(P<0.01);转染BRMS1可以明显抑制2种胶质瘤细胞分泌MMP-2活性;pEGFP-BRMS1可以通过上调TIMP-2的表达从而抑制MMP-2蛋白表达.结论 BRMS1可以通过增加TIMP-2表达进而抑制MMP-2的表达,打破TIMP-2/MMP-2平衡,最终抑制胶质瘤细胞侵袭能力. Objective To investigate the effect and mechanism of breast cancer metastasis suppressor-1 (BRMS1) on the human glioma cells invasion.Methods Transfection of the pEGFP-BRMS1 plasmids into the U251 and U87 glioma cells were carried out using Lipofectamine 2000.We studied the role of BRMS1 in glioma cell invasion by matrigel cell invasion assay.We performed gelatin zymography to measure the matrix metalloproteinase (MMP)-2 activities in glioma cells and Western blotting to examine the tissue inhibitorof metalloproteinase-2 (TIMP-2) and MMP-2 proteins expression after BRMS1 restoration.Results Compared to the control plasmids,pEGFP-BRMS1 plasmids could increase the expression of BRMS1 in both glioma cells significantly.In cell invasion assay,BRMS1 inhibits cell invasion ability of U251 and U87 cells in matrigel-coated Boyden chamber by 43% and 52%,respectively.BRMS1 also suppress the MMP-2 activity.Increasing of BRMS1 expression upregulated TIMP-2 protein expression and inhibited MMP-2 protein expression.Conclusion Our data indicate that BRMS1 may be reduced glioma cells invasion abilities by the imbalance between TIMP-2 and MMP-2.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第11期2327-2329,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(81201636) 江苏省自然科学基金资助项目(BK2012146)
关键词 乳腺癌转移抑制基因-1 胶质瘤 侵袭 金属蛋白酶组织抑制因子-2 基质金属蛋白酶-2 Keywords:Breast cancer metastasis suppressor-1 Glioma Invasion Tissue inhibitor of metalloproteinase-2 Matrix metalloproteinase-2
  • 相关文献

参考文献10

  • 1谢蕊繁,张所军,高宝成,万锋,郭东生,雷霆.基质金属蛋白酶抑制剂对胶质瘤细胞和胶质瘤干细胞体外侵袭抑制作用的比较[J].中华实验外科杂志,2010,27(10):1378-1380. 被引量:8
  • 2Seraj MJ,Samant HS,Verderame MF,et al.Functional evidence for anovel human breast carcinoma metastasis suppressor,BRMSl,enco-ded at chromosome llql3.Cancer Res,2000,60:2764-2769.
  • 3Shevde LA,Samant RS,Goldberg SF,et al.Suppression of humanmelanoma metastasis by the metastasis suppressor gene,BRMSl.ExpCell Res,2002,273:229-239.
  • 4Zhang S,Lin QD,Di W.Suppression of human ovarian carcinoma me-tastasis by the metastasis-suppressor gene,BHMSl.Int J GynecolCancer,2006,16:522-531.
  • 5Nagji AS,Liu Y,Stelow EB,et al.BRMSl transcriptional repressioncorrelates with CpG methylation and advanced pathological stage innon-small cell lung cancer.J Pathol,2010,221:229-237.
  • 6Wu YH5Jiang WJ,Wang YM,et al.Breast cancer metastasis suppres-sor I regulates hepatocellular carcinoma cell apoptosis via suppressingosteopontin expression.Plos One,2012,7:e42976.
  • 7Trojanek J.Matrix metalloproteinases and their tissue inhibitors.Postepy Biochem,2012,58:353-362.
  • 8Zhao J,Li G,Zhao Z,et al.Matrix metalloproteinase-9 expression isincreased in astrocytic glioma and associated with prognosis of pa-tients.Jpn J Clin Oncol,2012,42:1060-1065.
  • 9Mohanam S,Wang SW,Rayford A,et al.Expression of tissue inhibi-tors of metalloproteinases:negative regulators of human glioblastomainvasion in vivo.Clin Exp Metastasis,1995,13:57-62.
  • 10Lambert E,Dasse E,Haye B,et al.TIMPs as multifacial proteins.CritRev Onclo Hematol,2004,49:187-198.

二级参考文献12

  • 1陈雷,林建华,张声.基质金属蛋白酶-9和组织金属蛋白酶抑制剂-1在骨肉瘤中的表达及其意义[J].中华实验外科杂志,2004,21(12):1522-1523. 被引量:11
  • 2雒洪志,周总光,杨烈,周斌,田超,于永扬.基质溶解因子基因在人直肠癌中的表达及其临床意义[J].中华实验外科杂志,2005,22(11):1348-1349. 被引量:8
  • 3Park CM,Park MJ,Kwak HJ,et al.Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.Cancer Res,2006,66:8511-8519.
  • 4Bellail AC,Hunter SB,Brat DJ,et al.Microregional extra-cellular matrix heterogeneity in brain modulates glioma cell invasion.Int J Biochem Cell Biol,2004,36:1046-1069.
  • 5Levicar N,Nutall RK,Lah TT.Protease in brain tumour progression.Acta Neurochir,2003,145:825-838.
  • 6Wang M,Wang T,Liu S,et al.The expression of matrix metallopoteinase-2 and-9 in human gliomas of different pathological grades.Brain Tumor Pathol,2003,20:65-72.
  • 7Guo P,Imanishi Y,Cackowski FC.Up-regulation of angiopoietin-2,matrix metalloprotease-2,membrane type 1 metalloprotease,and laminin 5 gamma 2 correlates with the invasiveness of human glioma.Am J Pathol,2005,166:877-890.
  • 8Bao S,Wu Q,McLendon RE,et al.Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.Nature,2006,444:756-760.
  • 9Liu G,Yuan X,Zeng Z,et al.Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma.Mol Cancer,2006,5:67.
  • 10Del Duca D,Werbowetski T,Del Maestro RF.Spheroid preparation from hanging drops:characterization of a model of brain tumor invasion.J Neurooncol,2004,67:295-303.

共引文献7

同被引文献51

  • 1Petroski MD, Deshaies RJ. Function and regulation of Cullin-RING ubiquitin ligases [ J ]. Nat Rev Mol Cell Bio1,2005,6 (1) :9-20.
  • 2Min KW, Kim DH, Do SI,et al. Diagnostic anti prognostic relevance of Cullinl expression in invasive ductal carcinoma of the breast [ J ]. Clin Pathol, 2012,6 ( 5 ) : 896 -901.
  • 3Melchor L, Saucedo-Cuevas LP, Mulloz-Repelo'l,et al. Comprehen- sive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDPI and CUIAA as likely candidate target genes [ J ]. Breast Cancer Res ,2009,11 (6) : R86.
  • 4Bumatowska-Hledin MA, Kossoris J B, V an Dort C J, et al. T47 D breast cancer cell growth is inhibited by expression of VACM-I, a eul-5 gene [ J ]. Biochem Biophys Res Commun, 2004,319 ( 3 ) : 817-825.
  • 5Yasui K, Arii S ,Zhao C ,et al. TFDP1 ,CU[AA, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas[ J ]. Hepatology ,2002,35 ( 6 ) : 1476-1484.
  • 6Peng Z,Wang H,Shan C. Expression of ubiquitin and Cullin-I and its clinicopathological significance in benign and malignant lesions of the lung[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2009,34(3) : 204 -209.
  • 7Baxter SS, Carlson LA, Mayer AM, et al. Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5 [ J ]. In Vitro Cell Dev Biol Anita,2009,45 (5-6) : 264-274.
  • 8Paradis V,Albuquerque M, Mebarki M, et al. Cullin7 : a new gene in- volved in liver carcinogenesis related to metabolic syndrome [ J ]. Gut, 2013,62(6) :909-911.
  • 9Kim SS,Shago M,Kaustov L,et al. CUL7 is a novel antiapoptotic on- cogene [ J ]. Cancer Res,2007,67 (20) :9616-9622.
  • 10黄平,唐秋英,金瑛,陈光元.Bcl-2蛋白在宫颈癌变组织中的表达及其与人乳头瘤病毒感染的关联性[J].海南医学,2013,24(1):3-5. 被引量:2

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部